Your browser doesn't support javascript.
loading
Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1.
Besse, B; Felip, E; Garcia Campelo, R; Cobo, M; Mascaux, C; Madroszyk, A; Cappuzzo, F; Hilgers, W; Romano, G; Denis, F; Viteri, S; Debieuvre, D; Galetta, D; Baldini, E; Razaq, M; Robinet, G; Maio, M; Delmonte, A; Roch, B; Masson, P; Schuette, W; Zer, A; Remon, J; Costantini, D; Vasseur, B; Dziadziuszko, R; Giaccone, G.
Affiliation
  • Besse B; Paris-Saclay University, Cancer Medicine Department, Institut Gustave Roussy, Villejuif, France. Electronic address: Benjamin.BESSE@gustaveroussy.fr.
  • Felip E; Oncology Department, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona.
  • Garcia Campelo R; Medical Oncology Department, Complejo Hospitalario Universitario A Coruña, Biomedical Research Institute, INIBIC, A Coruña.
  • Cobo M; Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, Málaga, Spain.
  • Mascaux C; Pneumology Department, Hôpitaux Universitaires de Strasbourg-Nouvel Hôpital Civil, Strasbourg.
  • Madroszyk A; Medical Oncology Department, IPC-Institut Paoli-Calmettes, Marseille, France.
  • Cappuzzo F; Oncology Department, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Hilgers W; Medical Oncology Department, Sainte Catherine Cancer Center, Avignon, France.
  • Romano G; Medical Oncology Department, Ospedale Vito Fazzi-ASL Lecce, Lecce, Italy.
  • Denis F; Medical Oncology Department, Institut Inter-Régional de Cancérologie Jean Bernard-Elsan, Le Mans, France.
  • Viteri S; Medical Oncology Department, Instituto Oncológico Dr. Rosell, Hospital Universitario Dexeus, Grupo Quironsalud, Barcelona, Spain.
  • Debieuvre D; Pneumology Department, Groupe Hospitalier de la Région Mulhouse Sud Alsace, Mulhouse, France.
  • Galetta D; Medical Thoracic Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari.
  • Baldini E; Oncology Department, Ospedale San Luca, Lucca, Italy.
  • Razaq M; Oncology Department, Stephenson Cancer Center, Oklahoma City, USA.
  • Robinet G; Oncology Department, Centre Hospitalier Régional Universitaire Morvan, Brest, France.
  • Maio M; Department of Oncology, University of Siena and Center for Immuno-Oncology, University Hospital, Siena.
  • Delmonte A; Thoracic Department, IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" (IRST), Meldola, Italy.
  • Roch B; Thoracic Oncology Unit, Montpellier University, University Hospital of Montpellier, Montpellier.
  • Masson P; Pneumology Department, Centre Hospitalier de Cholet, Cholet, France.
  • Schuette W; Medical Oncology Department, Hospital Martha-Maria Halle-Doelau, Halle, Germany.
  • Zer A; Thoracic Cancer Service, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel.
  • Remon J; Paris-Saclay University, Cancer Medicine Department, Institut Gustave Roussy, Villejuif, France.
  • Costantini D; Medical Development Department, OSE Immunotherapeutics, Paris, France.
  • Vasseur B; Medical Development Department, OSE Immunotherapeutics, Paris, France.
  • Dziadziuszko R; Oncology and Radiotherapy Department and Early Phase Clinical Trials Centre, Medical University of Gdansk, Gdansk, Poland.
  • Giaccone G; Meyer Cancer Center, Weill Cornell Medicine, New York, USA.
Ann Oncol ; 34(10): 920-933, 2023 10.
Article in En | MEDLINE | ID: mdl-37704166
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 4_TD Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Cancer Vaccines / COVID-19 / Lung Neoplasms Type of study: Clinical_trials / Etiology_studies / Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Ann Oncol Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 4_TD Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Cancer Vaccines / COVID-19 / Lung Neoplasms Type of study: Clinical_trials / Etiology_studies / Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Ann Oncol Year: 2023 Document type: Article